Groupe la Francaise’s Checkpoint Therapeutics CKPT Stock Holding History

Groupe la Francaise’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-840,000	Closed	-$3.39M	–	457
2025 Q1	$3.39M	Buy	+840,000	New	+$2.8M	0.07%	178

Groupe la Francaise's CKPT Position: Q2 2025 in Review

Groupe la Francaise sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 840,000 shares — an estimated $3.39M sold.

Groupe la Francaise first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $3.39M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Groupe la Francaise reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Groupe la Francaise sold 840,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $3.39M.
Groupe la Francaise first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Groupe la Francaise's Checkpoint Therapeutics position peaked at $3.39M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Groupe la Francaise's 13F filing for Q2 2025, filed 13 Aug 2025.